Recent studies demonstrated that elevated expression of NXPH4 in human cancer cell lines and human serum is linked to hepatocellular carcinoma (HCC), suggesting this gene is a potential biomarker for the pathology [42,43]. This evidence concerns the gene NXPH4 and hepatocellular carcinoma.